ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022

[Profound survival benefit with concurrent chemotherapy: insights from a Chinese phase III trial in older patients with esophageal cancer].

Claudia Schweizer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.